Navigation Links
Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
Date:5/15/2008

SAN FRANCISCO, May 15 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that data from an ongoing Phase 1-2 clinical trial of its novel androgen receptor antagonist, MDV3100, will be presented in an oral presentation at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Session title: New Targeted Strategies for Patients with Prostate Cancer

Session date and time: Monday, June 2 at 11:30 a.m. Central Time

Abstract title: "Phase 1-2 Study of MDV3100 in Patients with Progressive

Castration-Resistant Prostate Cancer (CRPC)" (Abstract #5006)

To be presented by: Howard Scher, M.D., chief of the Genitourinary

Oncology Service and the D. Wayne Calloway Chair in Urologic Oncology at

Memorial Sloan-Kettering Cancer Center in New York, at approximately 12:15

p.m. Central Time

Location: W375e

Dr. Scher's presentation will include data appearing in the abstract posted today on the ASCO website, as well as additional study data not reflected in the abstract.

Medivation's ongoing Phase 1-2 trial of MDV3100 is an open-label dose-escalation study enrolling prostate cancer patients who have failed standard hormonal therapies. The study endpoints include safety, tolerability, pharmacokinetics, effects on serum PSA levels and disease progression. Medivation expects to complete the study and report final top-line results in 2008.

About Prostate Cancer

Prostate cancer is the most common type of cancer, other than skin cancer, and the second leading cause of cancer death in American men. More than 1 million men in the United States have prostate cancer. An estimated 186,320 new cases are expected to be diagnosed in 200
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related medicine technology :

1. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
2. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
3. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
4. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...SNewswire/ -- The ,Help is Here Express, bus tour ...oughout the week of November 9-13 at various citie...gling patients access information on programs that... free. With the nation,s unemployment rate now hit...n Assistance (PPA) bus tour is raising awareness o...
(Date:11/6/2009)... Facet Solutions, Inc. announced today that it has... The acquisition creates an undisputed leadership ...ty and clinical experience in posterior motion pre...rom lumbar spinal stenosis," stated Facet Solution...idation further strengthens Facet Solutions, posit...
(Date:11/6/2009)...Call/ -- Virtual Health Technologies, Inc. (OTC Bu...ously confirmed Letter of Intent to sell all healt...gies, Inc (WNDM) is subject to final approval of ... ,, Shareholder Assurances ,, "We believe ...and cash realized from the transaction would benef...
Breaking Medicine Technology:Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3Facet Solutions Acquires Archus Orthopedics 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Narconon Graduate Lives to Tell Story of Addiction 54131 1Narconon Graduate Lives to Tell Story of Addiction 54131 2CryoService Ltd Liquid Nitrogen Safety Training will Hit the Road Again in October 2009 54128 1CryoService Ltd Liquid Nitrogen Safety Training will Hit the Road Again in October 2009 54128 2Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 1Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 2Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 3Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 4Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 5Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 6Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 7Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 8Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 9Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 10Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 11Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 12Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 13Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 14Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 15Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 16Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 17Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 18Cardiac Science Reports Q2 Revenue 3B Resumes AED Shipments 54124 19
(Date:11/8/2009)... New book called "Preven...uot; by Dr. Roberto Giraldo shows that AIDS is a r...o a variety of so-called immune system stressor ag...itional and most of all, emotional. , ... -- From Nov. 6 – 8, 2009, cell biologists, ...
(Date:11/8/2009)..., WASHINGTON, Nov. 7 To...k, Pitts, Kaptur, Dahlkemper, Smith, Ellsworth and... for America Act" (H.R. 3962). The amendment maint...ing for abortion and for benefits packages that in...h those who receive affordability credits and thos...
(Date:11/8/2009)..., Calls for Swift Passage of H.R. 3961 to Secure ...PRNewswire-USNewswire/ -- Statement Attributable t...cal Association. ,, (Logo: http://www.newscom...AMA hails the passage of the House health reform b... patients and physicians and calls for swift passa...
(Date:11/8/2009)..., HOLLYWOOD, Calif., Nov. 8 /PRNewswire-USNewswire...ration of Babies luncheon to recognize prominent i...children and who are role models for March of Dime...part of the March of Dimes November Prematurity Aw...ests were urged to join the fight for preemies! ,...
(Date:11/7/2009)..., Jacquelyn T. Coleman (CT), David A. Cook (GA), ... L. Tarver (LA) Honored ,, CHICAGO, Nov. 7 /PR...iation (AMA) today presented five medical society ... their contributions to the goals and ideals of th... the AMA,s semi-annual policy making meeting in Ho...
Breaking Medicine News(10 mins):Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors Medical Society Executives 2
...College, an addiction treatment center in Woodland...ogram for young adults ages 17-26 in search of sub...ironment. The college is launching new life skill...fe skills while they complete a comprehensive drug...
...ow that Thomas Edison deliberately mined his uncon...mous naps while holding a brick. As the brick fell...patents. Drawing on three degrees in psychology an... to access it. During her four day seminar, "...
...cil (NIC) has completed a new classified assessmen...U.S. security in the next 20 years by causing poli...rorism, or conflicts over water and other resource...ment itself is confidential, some analyses used as...
...7 State policies have a significant impact on the...rograms, and could play a key role in efforts to e...eatment approaches, reports a study in the June is...from scientific research in the substance abuse tr...
...ential use of human embryonic stem cells in clinic...oth scientific and public opinion. The current con...ld deals particularly with the ethical implication...over the whole future of developmental biology ov...
...k of venous thromboembolism, study finds , ... use of the oral drug rivaroxaban helps prevent po...surgery, British researchers say. , The risk of v...d patients receive a heparin-based preventive drug...
Other Medicine News:Health News:California Drug Rehab Program Launches New Life Skills Classes to Young Adults as Substance Abuse Treatment 2Health News:California Drug Rehab Program Launches New Life Skills Classes to Young Adults as Substance Abuse Treatment 3Health News:California Drug Rehab Program Launches New Life Skills Classes to Young Adults as Substance Abuse Treatment 4Health News:Researchers Revisit Edison's Method of Generating Olympic Level Ideas via Unique New Corporate Seminar 2Health News:Researchers Revisit Edison's Method of Generating Olympic Level Ideas via Unique New Corporate Seminar 3Health News:Climate change may challenge national security, classified report warns 2Health News:Climate change may challenge national security, classified report warns 3Health News:State policies influence drug treatment programs 2Health News:Stem cell research from an ethical point of view 2Health News:Oral Drug Helps Prevent Clotting After Hip Replacement 2
Pediatric Custom Nebulizers
...R-2 assessment test approved by the U.S Food and D...is, adriamycin-based chemotherapy selection and He...rapy selection. PathVysion is the only FISH-based ...package insert as an appropriate test to aid in th...
...3 can choose either the PARI LC PLUS® or PARI ... both:, ,Maximize aerosol output when the patient...ent exhales using two one-way valves. Baffles allo.... The result is a high percentage of particles in ...
...eloping diverse medical products for more than 58 ...n outstanding reputation for innovation, quality a...nally recognized brands include the Labtron® l... sundry products, Bristoline® microscopes, Hea...
Medicine Products: